Viyash Scientific Limited

VIYASH NSE Healthcare Pharmaceuticals
Microcap 250
₹257.60
-1.09%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.17.
  • Comfortable interest cover: operating profit covers interest about 9.5 times.
  • Return on capital employed is moderate at 13.4%.
  • Net profit margin is 6.6%.
  • Profit has compounded about 15% a year over five years.
  • Sales have compounded about 20% a year over five years.
  • Promoters hold a majority stake (61.31%).

!Watch-points

  • Return on equity is on the lower side at 7.4%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.55

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreStrong
7 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 11,337 Cr
Current Price₹ 257.60
High / Low₹ 298.00 / 178.13
Stock P/E54.345997
Book Value₹ 66.60
Dividend Yield0%
ROCE13.40%
ROE7.39%
Face Value₹ 2.00
Debt to Equity0.17
PEG Ratio0.70
EV / EBITDA13.35
Industry PE35.70
P/B Ratio3.8620691
EPS₹ 4.06
Debt₹ 490 Cr
PAT Margin6.58%
Cash PAT₹ 459 Cr
ICR9.46
Promoter Holding61.31%
FII Holding4.50%
DII Holding3.76%
Public Holding30.34%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 19.00%
5 Years 20.00%
3 Years 34.00%
TTM 53.00%
Compounded Profit Growth
10 Years 28.00%
5 Years 15.00%
3 Years 73.00%
TTM 148.00%
Stock Price CAGR
10 Years 7.00%
5 Years 2.00%
3 Years 43.00%
1 Year 41.00%
Return on Equity
10 Years 8.00%
5 Years 3.00%
3 Years 4.00%
Last Year 7.00%
Educational data only. Not a recommendation to buy, sell or hold any security.